Ultra-Rare Disease Drug Loargys Wins English Funding Ahead Of US FDA Verdict

 
• By Neena Brizmohun
  
NICE recommended the use of Loargys following a commercial agreement between NHS England and Immedica (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access